Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?

被引：7
|
作者：
Jelinek, Michael J. [1 ]
Vokes, Everett E. [2 ,3 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Univ Chicago Med, 5841 S Maryland Ave,MC 6092, Chicago, IL 60637 USA
[3] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 31期
关键词：
SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; MULTICENTER PHASE-II; OPEN-LABEL; INDUCTION CHEMOTHERAPY; PLUS CETUXIMAB; HUMAN-PAPILLOMAVIRUS; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; EGF RECEPTOR;
D O I：
10.1200/JCO.19.01981
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2807 / +
页数：9
相关论文
共 50 条
  • [31] Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer
    Cripps, C.
    Winquist, E.
    Devries, M. C.
    Stys-Norman, D.
    Gilbert, R.
    CURRENT ONCOLOGY, 2010, 17 (03) : 37 - 48
  • [32] The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
    Michel Zimmermann
    Abderrahim Zouhair
    David Azria
    Mahmut Ozsahin
    Radiation Oncology, 1
  • [33] Prognostic Role of Epidermal Growth Factor Receptor in Head and Neck Cancer: A Meta-Analysis
    Zhu, Xiaoli
    Zhang, Fengmei
    Zhang, Wei
    He, Jing
    Zhao, Yulan
    Chen, Xingming
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (06) : 387 - 397
  • [34] Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting
    Sok, John C.
    Coppelli, Francesca M.
    Thomas, Sufi M.
    Lango, Miriam N.
    Xi, Sichuan
    Hunt, Jennifer L.
    Freilino, Maria L.
    Graner, Michael W.
    Wikstrand, Carol J.
    Bigner, Darell D.
    Gooding, William E.
    Furnari, Frank B.
    Grandis, Jennifer R.
    CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5064 - 5073
  • [35] Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
    Sobani, Zain A.
    Sawant, Ashwin
    Jafri, Mikram
    Correa, Amit Keith
    Sahin, Ibrahim Halil
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 340 - 351
  • [36] Role of sialoglycan structures for the function of the epidermal growth factor receptor and the in vitro proliferation of head and neck cancer
    W. Bergler
    A. Stanek
    F. Riedel
    G. Petroianu
    K. Hörmann
    European Archives of Oto-Rhino-Laryngology, 1998, 255 : 414 - 419
  • [37] Role of sialoglycan structures for the function of the epidermal growth factor receptor and the in vitro proliferation of head and neck cancer
    Bergler, W
    Stanek, A
    Riedel, F
    Petroianu, G
    Horman, K
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1998, 255 (08) : 414 - 419
  • [38] Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer
    Ahsan, Aarif
    Hiniker, Susan M.
    Ramanand, Susmita G.
    Nyati, Shyam
    Hegde, Ashok
    Helman, Abigail
    Menawat, Radhika
    Bhojani, Mahaveer S.
    Lawrence, Theodore S.
    Nyati, Mukesh K.
    CANCER RESEARCH, 2010, 70 (07) : 2862 - 2869
  • [39] Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer
    Cohen, Ezra E. W.
    Haraf, Daniel J.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Brockstein, Bruce
    Lester, Eric P.
    Salama, Joseph K.
    Dekker, Allison
    Williams, Rosalyn
    Witt, Mary Ellyn
    Grushko, Tatyana A.
    Dignam, James J.
    Lingen, Mark W.
    Olopade, Olufunmilayo I.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3336 - 3343
  • [40] Polymorphisms of the Epidermal Growth Factor Receptor (EGFR) and Survival in Patients with Advanced Cancer of the Head and Neck (HNSCC)
    Stoehlmacher-Williams, Jan
    Obermann, Luise
    Ehninger, Gerhard
    Goekkurt, Eray
    ANTICANCER RESEARCH, 2012, 32 (02) : 421 - 425
12345